版权说明:本文档由用户提供并上传,收益归属内容提供方,若内容存在侵权,请进行举报或认领
文档简介
-23-PatentRightsPurchaseAgreement专利购买合同核心提示:ThisPatentRightsPurchaseAgreement(thisAgreement)ismadeandenteredintoasof_________,_________,_________(M,D,Y).(theEffectiveDate)betweenAAA,Inc.(AAA),andDDD,Inc.(DDD).1.DEFINITIONS.1.1CationicLipidmeansthosecompoundsdThisPatentRightsPurchaseAgreement(thisAgreement)ismadeandenteredintoasof_________,_________,_________(M,D,Y).(theEffectiveDate)betweenAAA,Inc.(AAA),andDDD,Inc.(DDD).1.DEFINITIONS.1.1CationicLipidmeansthosecompoundsdescribedinUnitedStatesPatentNos._________and_________;UnitedStatesPatentApplicationSerialNo._________;andEuropeanPatentApplicationNo._________,totheextentsuchcompoundsarenotCodeblockerCompounds.1.2CodeblockerCompoundmeansanoligonucleotidethatbindsdirectlytoDNAorRNAwithinacellonaselectivebasisdeterminedbythenucleotidesequenceofthetargetDNAorRNAandexertsitsbiologicalactivitypredominantlythroughbindingtoDNAorRNAtoinhibitthetranscriptionorreplicationofthetargetDNAorRNAorbindingtoRNAtoinhibitthetranslation,processing,packagingorregulatoryactivityofthetargetRNA.ACodeblockerCompoundmayalsohaveamechanismofactionorbiologicalactivityotherthanoneconferredthroughdirectbindingtoRNAorDNAprovidedthat(i)thecompoundoriginallywasdesignedtobindatargetDNAorRNAand(ii)thefinalcompoundoranycompoundsusedtoderivethefinalcompoundwerenotidentifiedusingselectivepurificationandpolymeraseamplificationinanyfashion.Anoligonucleotide,isanyoligomerorpolymermadeup_________AnoligonucleotideincludesRNAorDNAfragments,andmaybecomposedofnaturallyoccurringornon-naturallyoccurringbases,sugarsorintersugarlinkages.Anoligonucleotidemayhavethebases,sugarsorintersugarlinkagespartiallyorcompletelyabsent.Oligonucleotidesmaybemadesuchthatadjacentnucleosideornucleosidefragmentsarelinkedtogetherbyphosphategroupsormodifiedornon-naturallyoccurringinternucleosidelinkagestoformtheinternucleosidebackboneoftheoligomer,whetherornotsuchlinkagesretainaphosphorousatominthelinkage.1.3OligonucleotideDeliverySystemmeansanycarrier,targetingentity,excipient,formulation,device,prodrug,covalentornoncovalentconjugate,encapsulatingvesicle,microcapsule,micro-ornanosphere,emulsion,ormicroemulsion,lipid,liposome,virosome,orartificialvialenvelopewhichwasdevelopedbyDDDonorpriortotheEffectiveDate,andwhich(i)enhancesthecellularpenetrationorcirculatinghalf-lifeofaCodeblockerCompound,(ii)selectivelydeliversaCodeblockercompoundtotheintendedtargettissue,cellorsubcellularcompartment,(iii)providessustainedreleaseofaCodeblockerCompoundfromadepotformulation,or(iv)otherwisefavorablyalterstheabsorption,distribution,metabolismorexcretionofaCodeblockerCompoundsoastoenhanceitspharmacologicalactivityofclinicalvalue.OligonucleotideDeliverySystemincludescationiclipids.1.4PatentRightsmeansthepatentsandpatentapplicationslistedinExhibitAattachedhereto.2.ASSIGNMENTSANDLICENSES.2.1DDDherebysellsandassignstoAAAallofDDD’sright,titleandinterestinPatentRights,subjecttotherightsofEEEInc.(EEE)undertheCollaborativeResearchAgreementbetweenEEEandDDDdated_________,_________,_________(M,D,Y)(theEEEAgreement),providedhowever,thattheassignmentofU.S.PatentNumber_________shallbesubjecttotheconditionprecedentthatDDDsettletheinterferenceinvolvingthispatentonconditionsofDDD’schoosing(includingconcedingpriority).DDDherebygrantsAAAanexclusive,royalty-free,worldwide,assignablelicense(withtherighttograntsublicenses)toU.S.PatentNumber_________beginningontheEffectiveDateandcontinuinguntilsuchtimethatDDDsettlestheinterferenceandtheassignmenttoAAAbecomeseffective.2.2DDDherebyassignsanddelegatestoAAA(andAAAacceptsandagreestoperform)allofDDD’srightsandobligationsundertheLicenseAgreementbetweenFFFCorporation(FFF)andDDDdated_________,_________,_________(M,D,Y)andamendedon_________,_________,_________(M,D,Y).AcopyofthewrittenconsenttosuchassignmentanddelegationsignedbyFFFisattachedheretoasExhibitB.IntheeventthatAAA,byreasonofthisAgreement,isrequiredtoindemnifyFFFunderSection8.1(b)oftheFFFLicenseAgreement,DDDwillindemnifyAAAuptoamaximumamountequaltoonehundredpercent(100%)oftotalroyaltiesreceivedbyDDDfromFFF;thereafter,DDDwillnothaveanyindemnityobligationstoAAArelatedtosuchAgreement.DDDwillcontinuetohonoritsobligationstoFFFforactivitiesprecedingtheEffectiveDateofthisAgreement.2.3SubjecttotherightsofFFFabove,AAAherebygrantstoDDDanexclusive,perpetual,irrevocable,royalty-free,worldwide,assignablelicense(withtherighttograntsublicenses)todirectlyorindirectlymake,havemade,use,import,exportorsellcompoundsandothersubjectmatterfallingwithinthescopeofPatentRightswhichare_________2.4DDDherebygrantstoAAAanonexclusive,perpetual,royalty-free,worldwide,assignablelicense(withtherighttograntsublicenses)tocompoundsandothersubjectmatterwhicharewithinthescopeofPatentRights,solelyforuseasintermediatesinthemanufactureofCodeblockerCompoundsoroligomers_________2.5AAAherebygrantstoDDDanon-exclusive,non-sublicensable,non-assignable,perpetual,irrevocable,royalty-free,worldwidelicenseunderPatentRightstomakeanduseCodeblockerCompoundsandOligonucleotideDeliverySystemsforinternalresearchpurposes,butnotforanycommercialpurpose.2.6AAAwillnothaveanyobligationstoDDDrelatingtoCodeblockerCompoundsorthisAgreementtotheextentarisingpriortotheEffectiveDate.2.7EachpartyherebyagreestoexecutesuchdocumentsandtotakesuchotheractionsasshallbenecessaryorappropriatetoeffectuatetheassignmentsandlicensessetforthinthisSection2.3.REPRESENTATIONSANDWARRANTIESBYDDD.DDDmakesthefollowingrepresentationsandwarrantiestoAAA,eachofwhichwillsurvivetheEffectiveDate:3.1TothebestofDDD’sknowledge,thePatentRightsincludeallofthepatentsandpatentapplicationsownedorcontrolledbyDDDonorpriortotheEffectiveDatethatcoverCodeblockerCompoundsandOligonucleotideDeliverySystems,theirmanufactureoruse.TherearenootherUSorunpublishedforeignfilingsownedorcontrolledbyDDDfiledpriortotheEffectiveDatewhichclaimCodeblockerCompoundsorOligonucleotideDeliverySystemsotherthanassetforthinExhibitA,nordoesDDDhaveanypresentintentiontomakesuchfilings.IfDDDbecomesawareofanypatentsorpatentapplicationsthat(i)areownedorcontrolledbyDDD,(ii)claiminventionsmadepriortotheEffectiveDate,(iii)coverCodeblockerCompoundsorOligonucleotideDeliverySystems,and(iv)arenotincludedinExhibitA,DDDwillpromptlynotifyAAAinwritingandexecuteappropriatedocumentstotransfersuchpatentsandpatentapplicationstoAAA.3.2DDDrepresentsandAAAacknowledgesthat(i)theEEEAgreementremainsineffectandDDDandEEEhaveongoingrightsandobligationsthereunder,modifiedtotheextentspecificallysetforthinthisAgreementand(ii)thisAgreementisnotanassignmentofDDD’srightsorobligationsundertheEEEAgreementandthatAAAassumesnorightsorobligationstoEEEunderthisAgreement.DDDrepresentsthattheResearchTermandallrights,obligationsandfundingrelatingtheretoundertheEEEAgreementhavebeenterminated.DDDwillnotenterintoanyfutureamendmentstotheEEEAgreementwhichinanywayaffecttherightsofAAAhereunder.3.3TheEEEAgreementandthelicensetoFFFreferencedinSection2.2abovearetheonlylicensesandDDDisnotawareofanyotherthirdpartyrightsofanykindaffectingthePatentRights.ExceptwithrespecttoU.S.PatentNumber_________,whichissubjecttoaninterferenceproceeding,thePatentRightsarenotthesubjectofanypendinginterference,cancellationorotherprotestproceedingnototherwiseknowntoAAA,orotherwisesubjecttorightsorobligationstoanythirdpartyotherthanEEEandFFF.ThecompletetermsandconditionsofsuchrightsandobligationsrelatingtoEEEandFFFhavebeendisclosedtoAAA.3.4TherearenoCollaborationCompounds(asdefinedinSection1.7oftheEEEAgreement)andnoneweredevelopedduringtheResearchTermundertheEEEAgreement.DDDdoesnotoweanyroyaltiestoEEEoranythirdpartyundertheEEEAgreementnordoesDDDhaveanyknownorpendingclaimsagainstEEEarisingoutoftheEEEAgreement.TothebestofDDD’sknowledge,(i)EEEdoesnotoweanyroyaltiestoDDDoranythirdpartyundertheEEEAgreement,(ii)nordoesEEEhaveanyknownorpendingclaimsagainstDDDarisingoutoftheEEEAgreement.4.TECHNOLOGYTRANSFER.4.1DDDandAAAwillcooperateinthefilingandexecutionofanyandalldocumentsnecessarytoeffectuatetheassignmenttoAAAofthePatentRights,includingthefilingofassignmentsorothertransferoftitlecovenantswiththeU.S.PatentandTrademarkOfficeandforeignpatentofficesasapplicabletothePatentRights.Withinthirty(30)daysfromtheEffectiveDate,DDDwillnotifyallattorneyshandlingtheprosecutionofthePatentRightstocontacttheAAAPatentDepartmenttoprovideanimmediatestatusupdateonthePatentRightsandtopreparethedocumentsnecessarytotransferthePatentRightstoAAA.ThecostofrecordingassignmentsofthePatentRightswillbebornebyAAA.Withinforty-five(45)daysfromtheEffectiveDate,DDDanditscounselwillusetheirreasonablebesteffortstotransferallfilesandsupportingdocumentsrelatingtothePatentRightstoAAA,includingbutnotlimitedto,allinitialinventiondisclosuredocuments,alldocumentssenttotheU.S.PatentandTrademarkOfficeregardinginventionsandclaims,alldraftpatentapplications,allfilingorprosecutiondocumentssubmittedtothepatentoffices,andallfilewrappers.ConceptionnotebooksandallotherdocumentsinthepossessionorunderthecontrolofDDDoritscounselrelatingtoconceptionand/orreductiontopractice,suchasscientistnotebooksshallbeobtainedinaccordwithDDD’sordinarydocumentretentionandmadeavailabletoAAAuponAAA’reasonablerequest.AlldocumentstobeprovidedtoAAAhereunderaretobesentbyexpediteddeliveryservice.4.2DDDwillmakeappropriatescientificstaffavailabletoAAAforascientifictutorialonthesubjectmatterofthisAgreement,suchtutorialnottoexceedmorethan[***]fromDDD’sstaffandnottoobligateDDDtodiscloseanythirdpartyconfidentialinformation.5.PATENTMAINTENANCEANDPROSECUTIONRESPONSIBILITIES.5.1OnandaftertheEffectiveDate,AAAwilltakeresponsibilityforanyactionorproceedinginvolvingPatentRights.ThecostofrecordingtheassignmentofPatentRightsshallbebornesolelybyAAA.IfAAAelectsnottotakesuchresponsibilityinvolvingPatentRight(s)inaparticularcountrythenAAAwilltimelynotifyDDDandEEE30daysbeforethetimefutureactionisdue,andthereafterDDDorEEEshallundertakesuchresponsibility.IfDDDorEEEelectstodoso,AAAwillgrantanynecessaryauthoritytoDDD.DDDwilldeterminewhetherDDDorEEEshalltakesuchresponsibilityattheirexpense.AAAassumesnoobligationtoEEEasaresultofitsagreementwithDDDinthisSectionNOTICEOFINFRINGEMENT.AAAshallpromptlynotifyDDDinwritingofanyinfringementofanyassignedPatentRight(s)ofwhichitbecomesaware.5.3ENFORCEMENTOFPATENTS.ExceptasotherwisesetforthinthisSection,AAAmay,butshallnotberequiredto,prosecuteanyallegedinfringementorthreatenedinfringementofanyassignedPatentRight(s)ofwhichitisawareorwhichisbroughttoitsattention.AAAshallactinitsownnameandatitsownexpense.IfAAAhasfailedtoprosecuteunderthefirstsentenceofthisparagraphwithrespecttoallegedorthreatenedinfringementrelatingtoanyPatentRight(s)(i)twomonthsafterithasbeennotifiedinwritingofsuchallegedinfringement,or(ii)onemonthbeforethetimelimit,ifany,setforthintheappropriatelawsandregulationsforthefilingofsuchactions,whichevercomesfirst,DDD(oratitselectionEEE)may,butshallnotberequiredto,prosecuteanysuchallegedinfringementorthreatenedinfringementofaPatentwithinthePatentRights.Inanysuchevent,DDDorEEEshallbefreetoactinitsownnameandatitsownexpense.Notwithstandingtheforegoingandasbetweentheparties,DDDshallhavethesoleandexclusiverightofenforcementwithrespecttoanyallegedorthreatenedinfringementofanyrightwithinthescopeofthelicensegrantedinSection2.3ofthisAgreement.AAAshallcooperatefullywithDDDorEEEinanyactionbyDDDorEEE,respectively,underthisparagraph,includingifrequiredinordertobringsuchanaction,thefurnishingofapowerofattorney.6.INDEMNITYANDWARRANTY.6.1INDEMNITYBYAAA.AAAwillindemnify,save,defendandholdDDDanditsagents,directorsandemployeesharmlessfromandagainstanyandallsuits,claims,actions,demands,liabilities,expensesand/orloss,includingreasonablelegalexpenseandattorneysfees,resultingfromactivitiesunderthisagreementbyAAA.6.2INDEMNITYBYDDD.DDDwillindemnify,save,defendandholdAAAanditsagents,directorsandemployeesharmlessfromandagainstanyandallsuits,claims,actions,demands,liabilities,expensesand/orloss,includingreasonablelegalexpenseandattorneyfees,resultingfrom(i)DDD’s,DDD’ssublicensee’sorDDD’sassignee’sactivitiesunderthelicensesprovidedforinSections2.3and2.5;(ii)DDD’scontractualobligationstothirdpartiesincludingEEEandFFF,excepttotheextentresultingfromAAA’activitiesunderthisAgreement;or(iii)DDD’sexerciseofthePatentRightspriortotheEffectiveDate.6.3WARRANTY.DDDwarrantsthatithassufficientrightandtitletoenterintoandtoperformitsobligationsunderthisAgreement.EXCEPTASEXPRESSLYSETFORTHINTHISAGREEMENT,THEPARTIESDISCLAIMALLWARRANTIESOFANYNATURE,EXPRESSORIMPLIED,INCLUDINGWITHOUTLIMITATIONWARRANTIESOFVALIDITY,MERCHANTABILITY,NONINFRINGEMENT,ANDFITNESSFORAPARTICULARPURPOSE.7.CONFIDENTIALITY.ConfidentialInformationunderthetermsofthisAgreementisallinformationrelatingtothePatentRightssold,assignedorlicensedtoAAAunderSection2.1andtheTechnologyTransfertoAAAbyDDDunderSection4.1.DDDagreestotreattheConfidentialInformationasconfidentialandtoprotectandmaintaintheconfidentialitythereof.DDDwilluseatleastthesamestandardofcareasitusestoprotectitsownConfidentialInformationtoensurethatitsemployees,agents,andconsultantsdonotdiscloseormakeanyunauthorizeduseofsuchConfidentialInformation.DDDwillpromptlynotifyAAAupondiscoveryofanyunauthorizeduseordisclosureoftheConfidentialInformation.ConfidentialInformationwillnotincludeanyinformationwhichisgenerallyavailabletothepublic,isotherwisepartofthepublicdomainotherthanthroughanyactoromissionofDDDinbreachofthisAgreement,orwhichisrequiredtobedisclosedbylaworcontractenteredintopriortothisAgreement(providedthatAAAshallhavenoticethereofinadvancesothatitcanacttoprotectitsinterestsshoulditdecidetodoso).8.CONSIDERATION.AAAshallpayDDDthefollowingnoncontingent,non-refundablecashpaymentsasconsiderationfortheassignmentsprovidedforinthisAgreement:$,_________ontheEffectiveDate,$,_________onthefirstanniversaryoftheEffectiveDate,$,_________onthesecondanniversaryoftheEffectiveDate,and$,_________onthethirdanniversaryoftheEffectiveDate,fortotalpaymentsof$,_________.IntheeventthatAAAdefaultsonanyofthesepayments,afterthirty(30)daysnoticeandanopportunitytocure,thenownershipofallPatentRightswillautomaticallyreverttoDDDandAAAwilltakeallactionsreasonablyrequestedbyDDDforsuchpurposes,including,withoutlimitation,signinganddeliveringanyapplicableassignmentsandotherdocuments.AAAshallbeentitledtonodamagesexceedingtheconsiderationsetforthinthisSection8foranyuncuredclaimagainstDDDrespectingDDD’sperformanceorrepresentationshereunder.9.NOTICES.NoticesunderthisAgreementshallbesufficientonlyifpersonallydelivered,deliveredbyamajorcommercialrapiddeliverycourierservice,facsimileormailedbycertifiedorregisteredmail,returnreceiptrequested,toapartyatitsaddressessetforthasfollows:IftoAAA:AAA,Inc.Address:_________Attn:_________Facsimile:_________IftoDDD:Address:_________Attn:_________Facsimile:_________IftoEEE:Address:_________Attn:_________Facsimile:_________10.MISCELLANEOUS.IfanyprovisionofthisAgreementshallbeadjudgedbyanycourtofcompetentjurisdictiontobeunenforceableorinvalid,thatprovisionshallbelimitedoreliminatedtotheminimumextentnecessarytocontinuetoeffecttheintentoftheparties,andthisAgreementshallotherwiseremaininfullforceandeffectandenforceable.Anywaiversoramendmentsshallbeeffectiveonlyifmadeinwritingandsignedbyarepresentativeoftherespectivepartiesauthorizedtobindtheparties.ThisAgreementshallbegovernedbythelawsoftheStateofDelaware,excludingconflicts-of-lawprinciples.ThisAgreementisthecompleteandexclusivestatementofthemutualunderstandingofthepartiesandsupersedesandcancelsallpreviouswrittenandoralagreementsandcommunicationsrelatingtothesubjectmatterofthisAgreement,excludingtheConfidentialDisclosureAgreementbetweenthepartiesdated_________,_________,_________(M,D,Y).INWITNESSWHEREOF,thepartieshaveexecutedthisAgreementasofthedayandyearfirstindicated
温馨提示
- 1. 本站所有资源如无特殊说明,都需要本地电脑安装OFFICE2007和PDF阅读器。图纸软件为CAD,CAXA,PROE,UG,SolidWorks等.压缩文件请下载最新的WinRAR软件解压。
- 2. 本站的文档不包含任何第三方提供的附件图纸等,如果需要附件,请联系上传者。文件的所有权益归上传用户所有。
- 3. 本站RAR压缩包中若带图纸,网页内容里面会有图纸预览,若没有图纸预览就没有图纸。
- 4. 未经权益所有人同意不得将文件中的内容挪作商业或盈利用途。
- 5. 人人文库网仅提供信息存储空间,仅对用户上传内容的表现方式做保护处理,对用户上传分享的文档内容本身不做任何修改或编辑,并不能对任何下载内容负责。
- 6. 下载文件中如有侵权或不适当内容,请与我们联系,我们立即纠正。
- 7. 本站不保证下载资源的准确性、安全性和完整性, 同时也不承担用户因使用这些下载资源对自己和他人造成任何形式的伤害或损失。
最新文档
- 2023年刀轴式刨片机类资金需求报告
- 村卫生室基本工作制度
- 2024年全钽电解电容器密封玻璃项目资金需求报告代可行性研究报告
- 第七单元测试卷-2024-2025学年语文三年级上册统编版
- 第一单元测试卷(单元测试)-2024-2025学年六年级上册语文统编版
- 供配电工程及配套设施投标方案(技术方案)
- 冀教版八年级下册《Lesson 24 An E-mail to Grandpa》同步练习卷
- 考点06 分式方程(精练)(原卷版)
- 基坑支护工程施工方案
- 民法典解释合同三
- 北大版高等数学课后习题答案_完整版
- 撤销银行结算账户申请书
- 小学学科教学中如何渗透心理健康教育
- 技能大赛引导模式下康复治疗技术专业教学改革的探索研究
- 蒲地蓝消炎口服液治疗小儿急性上呼吸道感染的有效性探讨
- 免疫学技术和临床
- 完整版背负式高压细水雾灭火装置使用说明
- 法国“新浪潮”与“左岸派”
- 哆来咪中英文对照歌词
- 图像分析及识别_课件_11
- 委托银行代扣水费协议书
评论
0/150
提交评论